Aisling Capital IV LP 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-03 4:30 pm Purchase |
2021-03-16 | 13D | Marker Therapeutics, Inc. MRKR |
Aisling Capital IV LP | 464,285 5.460% |
464,285 (New Position) |
Filing |